Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis

Published:2021-04-28 Issue:5 Volume:35 Page:469-481
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Lin Dee,Thompson-Leduc Philippe,Ghelerter Isabelle,Nguyen Ha,Lafeuille Marie-Hélène,Benson Carmela,Mavros Panagiotis,Lefebvre Patrick

Funder

Johnson and Johnson

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-021-00815-y.pdf

Reference72 articles.

1. Organization, W.H. Rolling updates on coronavirus disease (COVID-19). 2020; https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. Accessed 2 Sep 2020.

2. World Health Organization (WHO). Psychosis, including schizophrenia. 2019 [cited 2019 22 Oct]; http://www.emro.who.int/health-topics/schizophrenia/index.html. Accessed 2 Sep 2020.

3. Emsley R, et al. The nature of relapse in schizophrenia. BMC Psychiatry. 2013;13:50.

4. Gopal S, et al. Caregiver burden in schizophrenia following paliperidone palmitate long acting injectables treatment: pooled analysis of two double-blind randomized phase three studies. NPJ Schizophr. 2017;3(1):23.

5. Lehman AF, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 Suppl):1–56.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults.;Expert Review of Neurotherapeutics;2024-02

2. Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes;Biomedicines;2024-01-12

3. Exploring the relationship of cognitive function with and without COVID-19 recovered schizophrenic patients;Frontiers in Public Health;2024-01-03

4. Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort Study;Drugs - Real World Outcomes;2023-12-21

5. Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction;Journal of Clinical Medicine;2023-11-08